Next Article in Journal
An Attenuated HSV-1-Derived Malaria Vaccine Expressing Liver-Stage Exported Proteins Induces Sterilizing Protection against Infectious Sporozoite Challenge
Next Article in Special Issue
An Online Experiment of NHS Information Framing on Mothers’ Vaccination Intention of Children against COVID-19
Previous Article in Journal
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease
Previous Article in Special Issue
Declared Intention (Not) to Be Vaccinated against COVID-19, and Actual Behavior—The Longitudinal Study in the Polish Sample
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

by
Helena Garcia-Llana
1,
Nayara Panizo
2,*,
Lorena Gandía
2,
Marisa Orti
3,
Elena Giménez-Civera
2,
Claudia Forquet
2,
Luis D’Marco
4,
Maria Jesús Puchades
2,
Mari Sargsyan
2,
Irina Sanchís
2,
Carmen Ribera
2,
Mª Inés Marco
2,
Cristela Moncho Ferrá
2,
Carmen María Pérez-Baylach
5,
Begoña Bonilla
6,
Francesc Moncho Francés
2,
Elisa Perez-Bernat
2,
Asunción Sancho
7 and
Jose Luis Górriz
2,8
1
Hospital Universitario La Paz-IdiPAZ, Nephrology Department, Universidad Internacional de La Rioja (UNIR), Centro de Estudios Superiores Cardenal Cisneros, Universidad Pontificia de Comillas de Madrid, 28006 Madrid, Spain
2
Nephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, 46010 Valencia, Spain
3
Preventive Medicine Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain
4
Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain
5
B-Braun AvitumValnefron Massamagrell Dialysis Centre, 46130 Massamagrell, Spain
6
B-Braun AvitumValnefron Valencia Dialysis Centre, 46021 Valencia, Spain
7
Nephrology Department, Hospital Universitario Dr. Peset, 46017 Valencia, Spain
8
Department of Medicine, University of Valencia, 46010 Valencia, Spain
*
Author to whom correspondence should be addressed.
Vaccines 2022, 10(2), 299; https://doi.org/10.3390/vaccines10020299
Submission received: 10 January 2022 / Revised: 11 February 2022 / Accepted: 12 February 2022 / Published: 16 February 2022

Abstract

The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.
Keywords: COVID-19; vaccination; psychological distress; chronic kidney disease COVID-19; vaccination; psychological distress; chronic kidney disease

Share and Cite

MDPI and ACS Style

Garcia-Llana, H.; Panizo, N.; Gandía, L.; Orti, M.; Giménez-Civera, E.; Forquet, C.; D’Marco, L.; Puchades, M.J.; Sargsyan, M.; Sanchís, I.; et al. COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study. Vaccines 2022, 10, 299. https://doi.org/10.3390/vaccines10020299

AMA Style

Garcia-Llana H, Panizo N, Gandía L, Orti M, Giménez-Civera E, Forquet C, D’Marco L, Puchades MJ, Sargsyan M, Sanchís I, et al. COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study. Vaccines. 2022; 10(2):299. https://doi.org/10.3390/vaccines10020299

Chicago/Turabian Style

Garcia-Llana, Helena, Nayara Panizo, Lorena Gandía, Marisa Orti, Elena Giménez-Civera, Claudia Forquet, Luis D’Marco, Maria Jesús Puchades, Mari Sargsyan, Irina Sanchís, and et al. 2022. "COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study" Vaccines 10, no. 2: 299. https://doi.org/10.3390/vaccines10020299

APA Style

Garcia-Llana, H., Panizo, N., Gandía, L., Orti, M., Giménez-Civera, E., Forquet, C., D’Marco, L., Puchades, M. J., Sargsyan, M., Sanchís, I., Ribera, C., Marco, M. I., Ferrá, C. M., Pérez-Baylach, C. M., Bonilla, B., Moncho Francés, F., Perez-Bernat, E., Sancho, A., & Górriz, J. L. (2022). COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study. Vaccines, 10(2), 299. https://doi.org/10.3390/vaccines10020299

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop